Name | (5S,8S,11S,14S)-14-(Chloroacetyl)-3,6,9,12-tetrahydroxy-5-(4-hydroxybenzyl)-8-isopropyl-11-methyl-1-phenyl-2-oxa-4,7,10,13-tetraazahexadeca-3,6,9,12-tetraen-16-oic acid |
---|---|
Synonyms |
(5S,8S,11S,14S)-14-(Chloroacetyl)-3,6,9,12-tetrahydroxy-5-(4-hydroxybenzyl)-8-isopropyl-11-methyl-1-phenyl-2-oxa-4,7,10,13-tetraazahexadeca-3,6,9,12-tetraen-16-oic acid
2-Oxa-4,7,10,13-tetraazahexadeca-3,6,9,12-tetraen-16-oic acid, 14-(2-chloroacetyl)-3,6,9,12-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-11-methyl-8-(1-methylethyl)-1-phenyl-, (5S,8S,11S,14S)- |
Description | Z-YVAD-CMK is a caspase-1 and caspase-3 inhibitor[1]. |
---|---|
Related Catalog | |
Target |
caspase-1, caspase-3[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 844.4±75.0 °C at 760 mmHg |
Molecular Formula | C30H37ClN4O9 |
Molecular Weight | 633.09 |
Flash Point | 464.5±37.1 °C |
Exact Mass | 632.224915 |
LogP | 6.72 |
Vapour Pressure | 0.0±3.3 mmHg at 25°C |
Index of Refraction | 1.601 |